People Background Check
Find People:

Richard L Carlton, Age 70Middletown, NJ

Get Report
Known as:
Richard S Carlton Richard A Carlton Rachel L Carlton Ricahrd L Carlton Rick L Carlton Dick L Carlton Richard Julsonnet Ellen Carlton
Related to:
Stephanie Christine Carlton 62

Richard Carlton Phones & Addresses

Middletown, NJ

12 Mount Vernon Sq, Verona, NJ 07044 (973) 857-5084

Paramus, NJ

Crystal Bay, NV

West Caldwell, NJ

New York, NY

Hackensack, NJ

12 Mount Vernon Sq, Verona, NJ 07044 (973) 534-0701

Show more

Work

Position: Administration/Managerial

Education

School / High School: New York Medical College 1969

Languages

English

Mentions for Richard L Carlton

Career records & work history

Medicine Doctors

Richard Carlton Photo 1

Dr. Richard M Carlton, Port Washington NY - MD (Doctor of Medicine)

Specialties:
Psychiatry
Dietetics
Nutrition
Address:
13 S Bayles Ave, Port Washington, NY 11050
(917) 697-4233 (Phone) (516) 767-4566 (Fax)
Languages:
English
Education:
Medical School
New York Medical College
Graduated: 1969

Richard A. Carlton

Specialties:
Thoracic Surgery, Cardiovascular Disease
Work:
Hickory Heart Lung/Vas AssocsHickory Heart Lung & Vascular Associates
420 N Ctr St STE 20, Hickory, NC 28601
(828) 323-1100 (phone) (828) 324-9189 (fax)
Education:
Medical School
University of Massachusetts Medical School
Graduated: 1981
Procedures:
Removal Procedures on the Lungs and Pleura, Coronary Artery Bypass, Endarterectomy, Heart Valve Procedures, Thoracic Aortic Aneurysm Repair, Thoracoscopy
Conditions:
Abdominal Aortic Aneurysm, Aortic Aneurism, Congenital Anomalies of the Heart, Lung Cancer, Thoracid Aortic Aneurysm
Languages:
English
Description:
Dr. Carlton graduated from the University of Massachusetts Medical School in 1981. He works in Hickory, NC and specializes in Thoracic Surgery and Cardiovascular Disease. Dr. Carlton is affiliated with Catawba Valley Medical Center and Frye Regional Medical Center.

Richard Carlton resumes & CV records

Resumes

Richard Carlton Photo 39

Facility Manager At Seton Family Of Hospitals

Location:
United States
Industry:
Hospital & Health Care
Richard Carlton Photo 40

Director - Government Contracts

Location:
12 Mount Vernon Sq, Verona, NJ 07044
Industry:
Consumer Goods
Work:
Arlo Corpration since Jan 2009
Director - Government Contracts R. Siskind and Company May 2007 - Mar 2008
VP Sales Nike May 2002 - Jul 2006
Senior VP / U.S. Director of Sales, Vision & Timing E. Gluck Corp. Feb 1998 - Feb 2002
VP Sales Casio Inc USA 1998 - 2002
National Sales Manager - Timepiece Casio 1994 - 1998
Natioal Sales Manager Estee Lauder 1987 - 1990
Executive Director of Marketing
Education:
New York University 1972 - 1976
Skills:
Marketing Strategy, Retail, Crm, Budgets, Sales Operations, Merchandising, Product Development, Leadership, Account Management, Brand Development, Product Marketing, Competitive Analysis, Negotiation, Marketing, Apparel, Team Leadership, Wholesale, Fmcg, Brand Management, Marketing Communications, E Commerce, Consumer Products, Digital Marketing, Teamwork, Start Ups, Business Strategy, Market Research, Inventory Management, Advertising, Online Marketing, Cross Functional Team Leadership, Forecasting, Social Media Marketing, Strategic Planning, Market Planning, Sporting Goods, Strategy, Enterprise Software, B2B, Trade Shows, Online Advertising, Pricing, Product Launch, Selling, P&L Management, Strategic Partnerships, Business Planning, Marketing Management, Customer Insight, Product Management
Richard Carlton Photo 41

Physician

Work:
Virtual Home Office
Physician
Richard Carlton Photo 42

Richard Carlton

Richard Carlton Photo 43

Richard Carlton

Richard Carlton Photo 44

Business Development And Brand Building

Location:
Greater New York City Area
Industry:
Luxury Goods & Jewelry

Publications & IP owners

Us Patents

Antibacterial Therapy With Bacteriophage Physico-Chemically Altered By Pegylation To Delay Inactivation By The Host Defense System

US Patent:
7332307, Feb 19, 2008
Filed:
Sep 11, 2003
Appl. No.:
10/659698
Inventors:
Richard M. Carlton - Port Washington NY, US
Carl R. Merril - Rockville MD, US
Sankar L. Adhya - Gaithersburg MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
Exponential Biotherapies, Inc. - New York NY
International Classification:
C12N 15/64
US Classification:
435 914
Abstract:
The present invention is directed to bacteriophage therapy, using methods which enable the bacteriophage to delay inactivation by any and all parts of the host defense system (HDS) against foreign objects. The HDS normally reduces the number of bacteriophage in an animal, which decreases the efficiency of the bacteriophage in killing the host bacteria present during an infection. Disclosed is a method of producing bacteriophage modified for anti-HDS purposes by physico-chemical alteration of the bacteriophage surface proteins, so that the altered bacteriophage remain active in the body for longer periods of time than the unmodified bacteriophage.

Virulent Phages To Control In Foodstuffs And In Food Processing Plants

US Patent:
7438901, Oct 21, 2008
Filed:
Jul 7, 2003
Appl. No.:
10/516507
Inventors:
Martin Loessner - Binz, CH
Richard M. Carlton - Port Washington NY, US
Assignee:
Exponential Biotherapies, Inc. - Port Washington NY
International Classification:
A01N 63/00
US Classification:
424 936
Abstract:
The present invention relates to virulent (lytic) phage from the Myoviridae family, preferably P100, alone or in combination with other virulent phages. P100 and the endolysin from P100 can be administered to food products, to the components that will be added to food products, and/or to the infrastructure of the food processing plants within which such food products are processed, or the containers or wraps in which such foods are stored and/or shipped, in order to reduce contamination. P100 can also be used in the present invention to identify bacteria present on (or within) foodstuffs, as well as those bacteria present in the equipment or the general environment of the food processing plants in which the foodstuffs are being processed and in animals infected with. The phage and the endolysin of the present invention can also be used to treat animals infected with. P100 will kill the bacteria that are within its host range with great efficiency and will propagate to high titer thereon.

Virulent Phages To Detect In Foodstuffs And In Food Processing Plants

US Patent:
8034552, Oct 11, 2011
Filed:
Aug 28, 2008
Appl. No.:
12/200375
Inventors:
Martin Loessner - Binz, CH
Richard Carlton - Port Washington NY, US
Assignee:
E.B.I. Food Safety B.V. - Ne Den Haag
International Classification:
C12Q 1/70
US Classification:
435 5, 424 936
Abstract:
The present invention relates to virulent (lytic) phage from the Myoviridae family, preferably P100, alone or in combination with other virulent phages. P100 and the endolysin from P100 can be administered to food products, to the components that will be added to food products, and/or to the infrastructure of the food processing plants within which such food products are processed, or the containers or wraps in which such foods are stored and/or shipped, in order to reduce contamination. P100 can also be used in the present invention to identify bacteria present on (or within) foodstuffs, as well as those bacteria present in the equipment or the general environment of the food processing plants in which the foodstuffs are being processed and in animals infected with. The phage and the endolysin of the present invention can also be used to treat animals infected with. P100 will kill the bacteria that are within its host range with great efficiency and will propagate to high titer thereon.

Antibacterial Therapy With Bacteriophage Physico-Chemically Altered To Delay Inactivation By The Host Defense System

US Patent:
2001004, Nov 22, 2001
Filed:
May 29, 2001
Appl. No.:
09/865717
Inventors:
Richard Carlton - Port Washington NY, US
Carl Merril - Rockville MD, US
Sankar Adhya - Gaithersburg MD, US
Assignee:
Exponential Biotherapies, Inc.
International Classification:
A61K048/00
C12N007/01
US Classification:
424/093210, 435/235100
Abstract:
The present invention is directed to bacteriophage therapy, using methods which enable the bacteriophage to delay inactivation by any and all parts of the host defense system (HDS) against foreign objects. The HDS normally reduces the number of bacteriophage in an animal, which decreases the efficiency of the bacteriophage in killing the host bacteria present during an infection. Disclosed is a method of producing bacteriophage modified for anti-HDS purposes by physico-chemical alteration of the bacteriophage surface proteins, so that the altered bacteriophage remain active in the body for longer periods of time than the unmodified bacteriophage.

Oxygenating Agents For Enhancing Host Responses To Microbial Infections

US Patent:
2006013, Jun 22, 2006
Filed:
Mar 26, 2003
Appl. No.:
10/509285
Inventors:
Richard Carlton - Port Washington NY, US
Jeffrey Galpin - Westlake Villages CA, US
International Classification:
A61K 38/42
A61K 9/70
A61K 9/127
US Classification:
424449000, 514006000, 424450000
Abstract:
Oxygenating agents are used in the present invention for the novel purpose of treating microbial infections. The invention takes advantage of the fact that the increase in tissue pOproduced thereby can enhance the efficacy of the body's own antimicrobial defenses (including tissue repair), while also improving the efficacy of adjunctive agents that may be co-administered, such as antimicrobial agents, antioxidants, cytokine modulators, endotoxin antagonists and growth factors. The oxygenating agents of the present invention achieve the desired increased pOin the tissues without having to resort to the risks and expenses of hyper-baric oxygen therapy (HBO). The oxygenating agents can be administered systemically, regionally, or topically.

Method For Increasing Algae Growth And The Use Thereof In Production Of Algae-Derived Biofuels And Other Chemical

US Patent:
2011026, Nov 3, 2011
Filed:
Apr 22, 2011
Appl. No.:
13/064883
Inventors:
Mark Holland - , US
Patrick Di Bello - , US
Richard M. Carlton - Port Washington NY, US
International Classification:
C12N 1/12
A01G 1/00
US Classification:
4352576, 4352571, 47 14
Abstract:
A method of increasing yield of cultivated algae, which entails the step of cultivating one or more species of algae in the presence of one or more species of PPFM bacteria, for at least a portion of the algae cultivation.

Method For Increasing Algae Growth And The Use Thereof In Production Of Algae-Derived Biofuels And Other Chemicals

US Patent:
2014028, Sep 25, 2014
Filed:
Jun 11, 2014
Appl. No.:
14/302134
Inventors:
- St. Louis MO, US
Patrick BiBello - St. Louis MO, US
Richard M. Carlton - Port Washington NY, US
International Classification:
A01G 33/00
US Classification:
47 14
Abstract:
A method of increasing yield of cultivated algae, which entails the step of cultivating one or more species of algae in the presence of one or more species of PPFM bacteria, for at least a portion of the algae cultivation.

Isbn (Books And Publications)

Cardiovascular-Interventional Technology Exam Review

Author:
Richard Carlton
ISBN #:
0397549458

Principles Of Radiographic Imaging: An Art And A Science

Author:
Richard Carlton
ISBN #:
0827336055

Principles Of Radiographic Imaging: An Art And A Science

Author:
Richard Carlton
ISBN #:
0766813002

Thomson Delmar Learning'S Principles Of Radiographic Positioning And Procedures Pocket Guide

Author:
Richard Carlton
ISBN #:
0766862461

Radiography Exam Review

Author:
Richard R. Carlton
ISBN #:
0397548990

Introduction To Radiography And Patient Care

Author:
Richard R. Carlton
ISBN #:
0721634656

Introduction To Radiography And Patient Care

Author:
Richard R. Carlton
ISBN #:
0721676626

Introduction To Radiologic Sciences And Patient Care

Author:
Richard R. Carlton
ISBN #:
0721697828

Possible Relatives

Dawn A Carlton  Debbie Carlton  Denise A Carlton  Darius Carlton  Diana L Carlton  Donna D Carlton  Duane C Carlton  Richard A Stamps  Richard A Standish  Richard L Standley 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.